Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20131108015322N8Phase 3Completed
Phase 3, randomised, double-blind trial of ropivacaine, fentanyl and sufentanil in pain (4 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Onset of sensory block, Duration of sensory block and 5 more. Started Oct 2024; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20131108015322N8.